MATCH Arm EAY131-T

**Semantic type:** Intellectual Product

**Definition:** The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with vismodegib in patients with cancers that have mutations in either the SMO or PTCH1 gene, excluding basal cell skin cancers.

**Synonyms:** - EAY131-T - T